A rare case of concomitant association of transient thyrotoxicosis due to painless thyroiditis, hypopituitarism and central diabetes insipidus following spontaneous pituitary apoplexy is presented.
Introduction
Pituitary apoplexy is characterized by a wide spectrum of clinical features, not only in mode of presentation but also in outcome.'-3 We treated a patient with a previously undiagnosed pituitary tumour in whom spontaneous pituitary apoplexy occurred. Subsequently, impairments of both anterior and posterior pituitary function and transient resolving thyrotoxicosis secondary to painless (silent) thyroiditis4'5 developed. To our knowledge, these events concomitant with pituitary apoplexy have not been previously reported.
Case report
A 61 year old post-menopausal Japanese housewife was admitted to Fukuoka University Hospital in May, 1986 with marked general malaise, polydipsia and weight loss which had became progressively worse during a 4-month period. She had experienced the abrupt onset of severe headache associated with nausea and blurring vision with diplopia. The visual disturbance and headache gradually improved but 3 mmol/l), hypernatraemia (143-151 mmol/l) and low specific gravity of urine. Test for C-reactive protein was negative and the erythrocyte sedimentation rate was 12 mm/h. An impairment in corticotrophin secretion was suspected from the low plasma cortisol (27.6 nmol/l at 08.00 h; normal 1 10-520 nmol/l) and the low urinary excretion of 1 7-hydroxycorticosteroids (1.1 mg/day; normal 1.9-6.1 mg/day) and 17-ketosteroids (0.6 mg/day; normal 3.1-8.8 mg/day), and an appropriate response to the rapid ACTH (Cortrosyn) test. Plasma ACTH and cortisol responses to ovine corticotrophin releasing hormone (ovine CRF: 100 tLg, i.v.) also were diminished. The anti-TSH receptor antibody (measured by thyrotrophin binding inhibiting immunoglobulin: TBII) was -6.9% (normal < ± 10%) and antipituitary antibodies (indirect immunofluorescence technique using rat pituitary GH3 cell and mouse pituitary AtT20 cell as the antigen)8 were negative. Both anti-thyroglobulin antibody (TGHA) and anti-microsomal antibody (MCHA) (haemagglutination assay) were repeatedly positive at the titres 1:200 to 1:400 and 1:800 to 1:2,560 (normal, both < 1:100), respectively. A thyroid scan with 9'Tc revealed no uptake in the thryoid area.
These findings led to the diagnosis of 'painless (silent) thyroiditis' with thyrotoxicosis.4'5 Within 3 weeks, she was biochemicaily euthyroid, while on no medication (free T3 3.7 pg/ml and free T4 21.4 pmol/1). Four weeks later, the thyroid hormone levels markedly fell to severe hypothyroid ranges (free T3 1.8 pg/ml, free T4 8.1 pmol/l and TSH < 1.3 mU/l). At that time repeated radioactive '9ITc uptake had risen despite a low uptake. Before replacement, the 24-h 1231I uptake was 33.7% (normal 10 to 40%). Repeated TRH stimulation resulted in a delayed response in plasma TSH, as noted in hypothalamic disorders9 (basal 5.1 mU/I and peak TSH 17.0 mU/l at 90 min). Hydrocortisone (25 mg/day) and subsequent L-thyroxine (50-100 jig/day) were given, with marked improvement in the general clinical condition.
When hydrocortisone was substituted, daily urine output abruptly increased to about 8 to 9 litres with low osmolality (less than 200 mmol/kg) and diabetes insipidus was suspected (so-called masked diabetes insipidus due to rapid development of hypopituitarism).2 After water deprivation for 8 h, plasma osmolality rose to 291 mmol/kg, but the urine osmolality remained low (231 mmol/ kg). Plasma antidiuretic hormones (ADH) were not elevated (all < 1.0 pg/dl; normal < 7.5 pg/dl).
With the administration of 5.0 U of pitressin, the urine osmolality rapidly increased (490 mmol/kg). A diagnosis of central diabetes insipidus was confirmed. The urine volume was controlled by treatment with intranasal desmopressin (10 to 15 Ag/day). Plasma PRL decreased gradually to normal ranges during 1 year from onset and there was a concomitant regression of the pituitary mass associated with partial arachnoid herniation of cerebrospinal fluid into the sella (partial empty sella) on CT and MRI'0"' (Figure 1c) . She is currently well and is being followed in the outpatient clinic on L-thyroxine (125 Aig/day), hydrocortisone (20 mg/day) and desmopressin (10 g/ day).
Discussion
Pituitary apoplexy is becoming increasingly recognized as a complication of pituitary adenomas, occurring in over 10% of cases."3 Manifestations typically include headache, meningeal irritation, and visual loss or ophthalmoplegia, or both, with additional features depending on the extent of spread of hypophyseal contents and haemorrhage. 
